These interactions are still under investigation, and findings are based only on laboratory observations
Bielmann A, Sambiagio N, Wehr N, Gerber-Lemaire S, Bochet CG, Curty C
Fourth, long-term clinical outcomes data - cirrhosis incidence, HCC rates, liver transplantation, and liver-related mortality assessed as primary endpoints in randomized trials - are not yet available and are urgently needed to move beyond surrogate histological endpoints
The multifaceted discipline of nanotechnology by biotechnology and pharmaceuticals allows for the production of new delivery systems with special features and the manipulation of materials at the nanoscale (1 to 100 nm) [252]
The tissue collection was conducted as described above